Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/04/2003US6528315 Transfection of preferential nucleotide sequences into aggregations; mix sample and nucleotide sequences, incubate, expose to electric pulse, recover transformed aggregations
03/04/2003US6528314 Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
03/04/2003US6528313 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression
03/04/2003US6528312 Nuclease inhibitor (G-Actin) or interleukin-10 (IL-10) use improving cell transfection; mixtures; polynucleotides; use gene therapy, vaccines
03/04/2003US6528311 Molecular genetic techniques to generate new or improved biological properties of organisms or cells; genetic recombination; locked in prophage; protein/metabolite expression; meiosis
03/04/2003US6528306 Engraftable human neural stem cells
03/04/2003US6528305 Method of producing infectious reovirus
03/04/2003US6528304 Eukaryotic cells expressing at their surface at least an HLA-G isoform and their applications
03/04/2003US6528303 Neuropeptide Y-Y5 receptor
03/04/2003US6528300 Glutaryl cephalosporin amidase from Pseudomonas diminuta BS-203
03/04/2003US6528297 Human lysozyme gene, its encoded polypeptide and the method for preparing them
03/04/2003US6528296 Site-specific; isolated DNA of given nucleotide sequence; use in genetic engineering and biochemistry in modifying and mapping DNA
03/04/2003US6528294 To effect protein phosphorylation; for use in diagnosis and therapy
03/04/2003US6528287 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells
03/04/2003US6528285 Rolling circle (RCR) model; use for transferring heterologous genes; high degree of stability and a broad host spectrum
03/04/2003US6528284 S-Region Transfer Activity-70 (SRTA-70); can be used as therapeutic agents in immune response modulation
03/04/2003US6528283 Members of the D52 Gene family
03/04/2003US6528281 DNA encoding human interleukin-11 receptor
03/04/2003US6528276 Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
03/04/2003US6528271 Drug screening
03/04/2003US6528270 Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions
03/04/2003US6528264 Glass slides having a coating of polymer such as polylysine covalently attached to a silane layer coating the slide; adding a diluent such as ethanolamine when attaching polylysine to the silane layer to enhance DNA immobilization
03/04/2003US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer
03/04/2003US6528262 Hybridization of cDNA from sense RNA with cDNA obtained from antisense RNA; DNA polymerase treatment; amplification and cloning
03/04/2003US6528259 Methods for detecting human methylenetetrahydrofolate reductase allelic variants
03/04/2003US6528257 Method for the simultaneous monitoring of individual mutants in mixed populations
03/04/2003US6528255 Proteases from gram positive organisms
03/04/2003US6528254 Incubating with a nucleic acid polymerase to form duplex and single-stranded nucleic acid; cleaving with FEN(5'flap-specific) nuclease to generate a signal
03/04/2003US6528252 Methods for identifying a protease inhibitor
03/04/2003US6528251 Transfecting a cell line susceptible to infection by HIV with a sequence from the pol gene of HIV, which sequence encodes a desired target enzyme
03/04/2003US6528250 Administering multiple low doses of the virus using intravenous route
03/04/2003US6528249 Protein activity screening of clones having DNA from uncultivated microorganisms
03/04/2003US6528245 Bone marrow cells as a source of neurons for brain and spinal cord repair
03/04/2003US6528087 Kits for forming protein-linked lipidic microparticles
03/04/2003US6528065 Attenuated dengue-3 virus vaccine
03/04/2003US6528063 Infectious bursal disease virus (IBDV); viral proteins transgenically expressed in plant cells or viral protein coding sequences cloned into an E. Coli expression system administered to poultry
03/04/2003US6528060 Therapeutic compounds
03/04/2003US6528056 Inhibition of viral infection using antigen-binding proteins
03/04/2003US6528055 Polypeptide for use in the diagnosis, treatment and prevention of infections, immune response defects and autoimmune diseases
03/04/2003US6528054 Comprise one or more breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a breast
03/04/2003US6528038 An immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting
03/04/2003US6527933 Biotin-tagged DNA samples are captured at the spots of avidin immoblized on filter membrane by biotin-avidin bonding
03/04/2003US6527112 Card-shaped storage case for articles of daily use and/or consumer articles
03/04/2003CA2421202A1 Endoglin-specific polypeptide, production and use thereof
03/04/2003CA2396887A1 Method for determining quinolon resistance of tubercle bacilli
03/04/2003CA1341423C Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
02/2003
02/28/2003CA2400887A1 Production of therapeutic proteins in transgenic cereal crops
02/28/2003CA2400601A1 Real-time gene quantification with internal standards
02/28/2003CA2400531A1 Human nhe2
02/28/2003CA2400521A1 Gpcr subfamily sequence motifs, and methods for gpcr characterization
02/28/2003CA2396891A1 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene
02/28/2003CA2357181A1 Generation of transgenic mouse models for the development of prostate cancer using regulatory regions of the psp94 gene
02/28/2003CA2356540A1 Expressed dna sequences involved in mitochondrial functions
02/28/2003CA2356536A1 Mitochondrial dna sequence alleles
02/28/2003CA2356473A1 Production of a herpes vaccine in the seeds of a cereal crop
02/27/2003WO2003017038A2 A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
02/27/2003WO2003016918A1 Micro flow passage device, connection device, and method of using the devices
02/27/2003WO2003016917A2 Sodium channel regulators and modulators
02/27/2003WO2003016573A1 Age-associated markers
02/27/2003WO2003016572A1 Oligonucleotide therapeutics for treating hepatitis c virus infections
02/27/2003WO2003016571A1 Zinc finger domain libraries
02/27/2003WO2003016568A2 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays
02/27/2003WO2003016567A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides
02/27/2003WO2003016565A2 Dna sequence analysis
02/27/2003WO2003016564A2 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods
02/27/2003WO2003016563A2 Novel molecular target for neurotoxicity
02/27/2003WO2003016552A2 Dna purification and recovery from high particulate and solids samples
02/27/2003WO2003016551A2 Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
02/27/2003WO2003016549A2 Nucleic-acid associated proteins
02/27/2003WO2003016548A2 Engineered rna translocators
02/27/2003WO2003016542A1 Obesity related genes expressed at least in the hypothalamus
02/27/2003WO2003016541A1 Premeabilisation of cells
02/27/2003WO2003016540A2 Humanised baculovirus
02/27/2003WO2003016539A1 Retroviral vectors for gene transfer into neuronal cells
02/27/2003WO2003016538A1 A method or extracellular production of target proteins employing ompf in e. coli
02/27/2003WO2003016537A2 Method for repairing a mutant rna from a dna with genetic defects and for the programmed death of tumour cells by rna trans-splicing as well as a method for identifying naturally trans-spliced cellular rna
02/27/2003WO2003016536A2 Plasmids from anaerocellum thermophilum and uses thereof
02/27/2003WO2003016535A2 Novel amylases and uses thereof
02/27/2003WO2003016533A1 GENE qSH-1 INDUCING PLANT THRESHABILITY AND UTILIZATION OF THE SAME
02/27/2003WO2003016532A1 Human protooncogene kg-20 and protein encoded therein
02/27/2003WO2003016531A1 RNA-BINDING PROTEIN Musashi 2
02/27/2003WO2003016530A1 Novel protein and its dna
02/27/2003WO2003016529A1 Novel blomia tropicalis antigens and uses therefor
02/27/2003WO2003016528A2 Oligonucleotide compositions and their use to induce apoptosis
02/27/2003WO2003016527A2 Process for the detection of oxidative stress and kit for its implementation
02/27/2003WO2003016525A1 Process for producing alcohol from starch
02/27/2003WO2003016524A1 Process for producing alcohol from starch
02/27/2003WO2003016522A2 Methods and compounds for the targeting of protein to exosomes
02/27/2003WO2003016521A2 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection
02/27/2003WO2003016519A1 METHOD FOR CLONING AND EXPRESSION OF AsiSI RESTRICTION ENDONUCLEASE AND AsiSI METHYLASE IN E.COLI
02/27/2003WO2003016518A1 Regulation of human triacylglycerol lipase
02/27/2003WO2003016517A2 Kinase crystal structures
02/27/2003WO2003016516A2 Kinase crystal structures and materials and methods for kinase activation
02/27/2003WO2003016511A1 Method of extended culture for antigen-specific cytotoxic t lumphocytes
02/27/2003WO2003016510A1 New biopesticide using gene from erwinia pyrifoliaewt#3, novel pathogen that affects asian pear trees
02/27/2003WO2003016506A2 Secreted proteins
02/27/2003WO2003016505A2 Kgf polypeptide compositions
02/27/2003WO2003016504A2 Polymorphisms associated with ion-channel disease
02/27/2003WO2003016503A2 Genes encoding carotenoid compounds
02/27/2003WO2003016501A2 Recombinant antibodies, and compositions and methods for making and using the same
1 ... 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 ... 4023